Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

9(90.0%)

Phase 2

1(10.0%)

10Total

N/A(9)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05946993Not ApplicableActive Not Recruiting

Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

Role: collaborator

NCT06646861Not ApplicableCompleted

Head and Neck Cancer Rehabilitation: The CaRe Feasibility Study

Role: collaborator

NCT05035173Not ApplicableCompleted

The LYSA (Linking You to Support and Advice) Trial

Role: collaborator

NCT05615285Not ApplicableCompleted

Personalised Exercise Rehabilitation for Cancer Survivorship

Role: collaborator

NCT05816460Not ApplicableUnknown

The Sleepio After Cancer Study

Role: collaborator

NCT04766229Phase 2Completed

The Menopause After Cancer Study

Role: collaborator

NCT05518591Not ApplicableUnknown

COMpassion FOcused Therapy and Breathing Pattern REtraining After Cancer Recurrence

Role: collaborator

NCT03979118Completed

Exercise Prescription in Patients With Bone Metastases

Role: collaborator

NCT03978325Not ApplicableUnknown

Preoperative Exercise for Patients Undergoing Complex Cancer Surgery

Role: collaborator

NCT04026659Not ApplicableCompleted

The Feasibility of Implementing an Exercise Programme for Deconditioned Cancer Survivors

Role: collaborator

NCT00348959Not ApplicableCompleted

An Evaluation of the Effect of 'Open Window' on Psychological Well-being and Experience of Stem Cell Transplantation

Role: collaborator

All 11 trials loaded